RISK OF CARDIOVASCULAR, GASTROINTESTINAL, AND RENAL ADVERSE EVENTS ASSOCIATED WITH DICLOFENAC IMMEDIATE AND EXTENDED RELEASE DRUG PRODUCTS: AN OBSERVATIONAL STUDY USING US CLAIMS DATA

被引：0
|
作者：
Mladsi, D. M. [1 ]
Goyal, R. K. [1 ]
Cryer, B. [2 ]
Hopkins, W. E. [3 ]
Brater, C. D. [4 ,5 ]
Korsnes, J. S. [1 ]
Candrilli, S. [1 ]
Castellsague, J. [6 ]
Varas-Lorenzo, C. [6 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Univ Texas Southwestern & VA North Texas Hlth Car, Dallas, TX USA
[3] Univ Vermont, Coll Med, S Burlington, VT USA
[4] Walther Canc Fdn, Indianapolis, IN USA
[5] Regenstrief Fdn, Indianapolis, IN USA
[6] RTI Hlth Solut, Barcelona, Spain
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1701
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY3
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 29 条
  • [21] Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users - A cohort study using pharmacy dispensing data in the Netherlands
    Layton, Deborah
    Souverein, Patrick C.
    Heerdink, Eibert R.
    Shakir, Saad A. W.
    Egberts, Antoine C. G.
    DRUG SAFETY, 2008, 31 (02) : 143 - 158
  • [22] Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor UsersA Cohort Study Using Pharmacy Dispensing Data in The Netherlands
    Deborah Layton
    Patrick C. Souverein
    Eibert R. Heerdink
    Saad A. W. Shakir
    Antoine C. G. Egberts
    Drug Safety, 2008, 31 : 143 - 158
  • [23] Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data
    Merola, Joseph F.
    Ertmer, Brennan
    Liang, Huifang
    Yue, Xiaomeng
    Ofori, Sarah
    Krueger, Whitney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (05) : 935 - 944
  • [24] Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et al.
    Berkowitz, Callie
    Wilson, Samuel
    Key, Nigel S.
    Ellsworth, Patrick
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (09) : 2674 - 2675
  • [25] Admission to Hospital with Acute Gout is Associated with a Short Term Increased Risk of Major Adverse Cardiovascular Events: A Longitudinal, Population-Level Linked Health Data Study in Western Australia
    Lopez, Derrick
    NOssent, Johannes
    Warren, Raymond
    Preen, David
    Inderjeeth, Charles
    Murray, Kevin
    Dwivedi, Girish
    Keen, Helen I.
    CIRCULATION, 2021, 144
  • [26] Authors' Reply to Michael Auerbach's Comment on: "Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System"
    Trumbo, Henry
    Kaluza, Karolina
    Numan, Syed
    Goodnough, Lawrence T.
    DRUG SAFETY, 2021, 44 (05) : 611 - 613
  • [27] Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System”
    Henry Trumbo
    Karolina Kaluza
    Syed Numan
    Lawrence T. Goodnough
    Drug Safety, 2021, 44 : 611 - 613
  • [28] Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records
    Zghebi, S. S.
    Steinke, D. T.
    Rutter, M. K.
    Emsley, R. A.
    Ashcroft, D. M.
    DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 916 - 924
  • [29] RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND A LOW-INTERMEDIATE A PRIORI RISK OF CORONARY ARTERY DISEASE AFTER INITIAL CT-BASED DIAGNOSIS AND TREATMENT A REGISTRY-BASED FOLLOW-UP STUDY USING DATA FROM THE WESTERN DENMARK HEART REGISTRY
    de Thurah, Annette
    Andersen, Ina Trolle
    Tinggaard, Andreas Bugge
    Riis, Anders Hammerich
    Therkildsen, Josephine
    Botker, Hans Erik
    Bottcher, Morten
    Hauge, Ellen-Margrethe
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1392 - 1392
123